Mirion Reports Q3 2026 Results and Raises Guidance

Nuclear Power
Nuclear Power
Earnings
Earnings
Merger:
Oct 20, 2021
Industry:
MEASURING & CONTROLLING DEVICES, NEC
Market Cap.:
3.60 bn.

Show Chart?

Load external content from TradingView!

*You can change or withdraw your consent at any time in the footer under Cookies.

Mirion Announces Third Quarter 2026 Financial Results and Raises Full Year Guidance

Atlanta, GA, USA - Mirion Technologies, Inc. (NYSE: MIR) announced its financial results for the third quarter ended September 30, 2026, reporting significant revenue growth and an increase in profitability. The global provider of radiation detection, measurement, analysis, and monitoring solutions also revised its full year 2026 guidance upward across multiple key metrics.

Revenues for the third quarter reached $277.8 million, marking a 24.5% increase compared to $223.1 million in the same period of 2025. GAAP net income for the quarter rose significantly to $7.8 million, up 151.6% from $3.1 million in the prior year period. Adjusted EBITDA reached $64.8 million, representing a 23.7% increase year-over-year.

Financial Highlights

  • Revenue Growth: Third quarter revenue increased 24.5% to $277.8 million.

  • Net Income: GAAP net income was $7.8 million, with GAAP net earnings per share at $0.03.

  • Adjusted EBITDA: Adjusted EBITDA was reported at $64.8 million, up 23.7% from the previous year.

  • Orders Performance: Third quarter orders grew 62% excluding recent acquisitions to $340 million, or 85% including acquisitions to $386 million.

Based on strong operational performance and increased visibility, Mirion revised its full year 2026 financial guidance. Total revenue growth is now projected at approximately 24% to 25%, and organic revenue growth is expected to be around 7% to 8%. Additionally, Adjusted EBITDA is forecasted between $285 million and $292 million.

About Mirion Technologies, Inc.

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

View Company Details

More MIR News

SPAC IPO Calendar
SPAC IPO Events
Scroll to Top